Announcements Trials
Browse Landscape

Phase

Phase 2 19Phase NA 12Phase 1/2 6Phase EARLY_PHASE1 5Phase 1 5Phase 4 2Phase 3 2

Status

Completed 9Recruiting 4Unknown 2Withdrawn 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 134Breast 66Lymphoid 62Other hematologic neoplasm 47Thoracic 40Genitourinary 34Head & Neck 21Tumor-Agnostic 20Dermatologic 18Gynecologic 17Classical hematology 14CNS 12Plasma cell 9Myeloid 9Other 8Endocrine 8Sarcoma 5Other solid neoplasm 4NET 2

Conditions

Neuroendocrine Tumors 2Disease 1

Interventions

lanreotide 1Positron Emission Tomography Computed Tomography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Unknown × NET × Clear all
NCT03083210 2019-05-20

Study of Lanreotide in Metastatic or Recurrent Grade I-II Hindgut NET

Samsung Medical Center

Phase 4 Unknown
28 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT02621541 2016-01-06

Nonfunctional Pancreatic NET and PET Imaging

Turku University Hospital

Phase 4 Unknown
20 enrolled
EndocrineNET

Disease, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡